Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine + Carboplatin + Paclitaxel +/- Bevacizumab in Advanced/Recurrent NSCLC
NCT00728845Phase 2Terminated
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Jun 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in non-small cell lung cancer (NSCLC), sponsored by University of Medicine and Dentistry of New Jersey. Started Jun 2008; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00728845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00728845.